ARCHIVES

In Brief: Parkinson To Leave CTEP For Novartis; FTC To Permit Sandoz, Ciba-Geigy Merger

This article is from The Cancer Letter archive.

Vol. 23 No. 01 | January 10, 1997

Download PDF Visit The Full Archive

Related Articles

New Mexico CBCCP Charges Contracts Terminated for “Mundane Political, Economic” Factors

April 25, 1980

Andrew von Eschenbach Sworn In As NCI Director.

January 25, 2002

Wallen Pleads Guilty To Lesser Charges, To Pay $20,000 to CALGB, FDA

August 31, 1984

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

October 1, 1976

Change In Method Of Counting Cancer Incidence Results In More Attributed To Work Hazards

October 6, 1978

New Cancer Education Grant Program Guidelines, Developed

February 6, 1987